The present invention is directed to devices and methods for determining the presence of analyte in a fluid sample. The devices utilize a sample collection well, an expression plate for expressing sample into the sample collection well, a plunger that drives a lance, and a test compartment containing test elements. The devices also preserve an aliquot of fluid sample in a reservoir for later confirmation testing. When the plunger is lowered into the sample collection well, a lance on the device punctures a frangible material that covers a sample outlet. When the sample outlet is thus opened, fluid sample flows from the sample collection cup to the test compartment. In one embodiment the plunger is lowered as a cap is applied to the device. The devices are useful for detecting the presence of analyte in a wide variety of fluid samples, such as saliva, oral fluids, and more. The invention also provides methods of using the devices, and kits containing the devices.

Patent
   7837939
Priority
Nov 14 2003
Filed
Aug 20 2007
Issued
Nov 23 2010
Expiry
Jan 24 2026
Extension
435 days
Assg.orig
Entity
Large
68
248
all paid
18. A kit comprising:
a device comprising
a casing, comprising a port for a sample collection well;
a sample collection well situated in the port, the sample collection well comprising an expression plate and a plunger, the plunger having a raised position and a lower position, the sample collection well further comprising a lower chamber when the plunger is in the raised position;
an upper chamber for storage of a confirmation sample;
a test compartment containing at least one test element;
a sample outlet sealed by a frangible material and providing liquid communication between the sample collection well and the test compartment when the sample outlet is open;
a lance for piercing the frangible material;
a cap for the sample collection well, wherein a portion of the cap interacts with the plunger to move the plunger from the raised position to the lower position when the cap is applied to the sample collection well; and
a sample applicator.
1. A test device for detecting an analyte suspected of being present in a fluid sample, comprising:
a casing, comprising a port for a sample collection well;
a sample collection well situated in the port, the sample well comprising an expression plate and a plunger, the plunger having a raised position and a lower position, the sample collection well further comprising a lower chamber when the plunger is in the raised position;
an upper chamber for storage of a confirmation sample;
a test compartment containing at least one test element;
a sample outlet sealed by a frangible material and providing liquid communication between the sample collection well and the test compartment when the sample outlet is open;
a lance for piercing the frangible material; and
a cap for the sample collection well, wherein a portion of the cap interacts with the plunger to move the plunger from the raised position to the lower position when the cap is applied to the sample collection well.
2. The device of claim 1 wherein the lance is carried on the plunger.
3. The test device of claim 1, wherein the expression plate divides the upper chamber from the lower chamber, and comprises an aperture for flow of liquid sample from the upper chamber to the lower chamber.
4. The device of claim 1 wherein the lance is downwardly-projecting and is perpendicularly aligned with the outlet for breaking the frangible material.
5. The device of claim 1 wherein the sample collection well and cap further comprise complementary engaging screw threads.
6. The device of claim 1 wherein the cap comprises a downward projection that interacts with the plunger when the cap is applied to the sample collection well.
7. The device of claim 6 wherein the expression plate comprises an opening through which the projection passes to interact with the plunger.
8. The device of claim 1 wherein the lower chamber is absent when the plunger is in the lower position.
9. The device of claim 1 wherein the frangible material is selected from the group consisting of paper, wax-coated paper, plastic-coated paper, plastic film, a thin plastic sheet, adhesive tape, foil, waxed foil and plastic-coated foil.
10. The device of claim 1 wherein the test element is a test strip.
11. The device of claim 1 wherein the test strip comprises specific binding molecules immobilized on the test strip.
12. The device of claim 1 the test strip further comprising a chemical test.
13. The device of claim 1 wherein the fluid sample is selected from the group consisting of oral fluid, blood, serum, plasma, urine, feces, spinal fluid, vaginal swabs, mucus, and tissue.
14. The device of claim 13 wherein the fluid sample is saliva.
15. The device of claim 1 wherein the analyte is selected from the group consisting of a drug, a hormone, a protein, a nucleic acid molecule, an etiological agent and a specific binding pair member.
16. The device of claim 15 wherein the analyte is a drug of abuse.
17. The device of claim 2 wherein the upper and lower chambers are present when the plunger is in the raised position, and the lower chamber is not present when the plunger is in the lower position.
19. The kit of claim 18 wherein the lance is carried on the plunger.
20. The kit of claim 19 wherein the sample applicator further comprises an absorbent member and a handle.
21. The kit of claim 20 wherein the absorbent member comprises a sponge.
22. The kit of claim 20 wherein the absorbent member comprises a foam.
23. The kit of claim 20 wherein the absorbent member comprises a solution that stimulates salivation in a test subject.

This application claims priority to PCT/US2004/038427, filed on Nov. 15, 2004; which claims priority to U.S. Provisional Application No. 60/520,437, filed Nov. 14, 2003, the contents of which are specifically incorporated herein.

The present invention is directed to devices for the rapid analysis of fluids for analytes of interest and the storage of those fluids.

The following Background of the Invention is intended to aid the reader in understanding the invention and is not admitted to be prior art.

Illicit drug use is an established and growing problem in our society. In 2003, the US Department of Health and Human Services found that an estimated 19.5 million Americans or 8.2 percent of the population aged 12 or older, were current illicit drug users. Current illicit drug use means use of an illicit drug during the month prior to the US Department of Health and Human Services survey interview. Marijuana was found to be the most commonly used illicit drug, with a rate of 6.2 percent (14.6 million). An estimated 2.3 million persons (1.0 percent) were current cocaine users, 604,000 of whom used crack. Hallucinogens were used by 1.0 million persons, and there were an estimated 119,000 current heroin users.

To combat and monitor this problem, drug testing has become standard procedure in a variety of settings, such as employment, school, sports, law enforcement, and the like. To facilitate this effort, a drug-testing industry has emerged. This industry provides a variety of drug testing products. A typical product is a urine collection cup incorporating analysis tests. These devices can be complicated and difficult or messy to use, or they may pose special problems of sample adulteration by the subject trying to hide their recent drug abuse.

There is therefore a need for better methods and apparatuses for performing sample collection and testing.

The present invention is directed to devices for detecting an analyte suspected of being present in a fluid sample. In one embodiment the devices are for detecting analytes of interest in body fluids, such as saliva or oral fluid. The devices have a casing which contains a port for positioning of a sample collection well. The sample collection well has a chamber for collection and storage of a confirmation sample, and contains a plunger which has a raised and a lower position. In some embodiments the sample collection well has an upper and a lower chamber, and the lower chamber is present when the plunger is in the lower position, and also collects fluid sample to be analyzed. The device also has a sample outlet sealed by a frangible material which provides liquid communication between the sample collection well and the test compartment when the sample outlet is open. The device also has an expression plate, which allows the user to express sample into the device from a sample applicator that has an absorbent member for collecting the fluid sample. In some embodiments the lance is attached to the bottom end of the plunger. The sample outlet is opened by moving the plunger to the lower position, which causes the lance to break the frangible material and open the sample outlet, thereby providing liquid communication between the sample collection well and the test compartment. In embodiments where a screw cap is used, the plunger is lowered by screwing on the cap, the bottom of which interacts with the plunger or a piece connected thereto, and forces the plunger into the lower position. Kits containing the devices, and methods of using the devices are also provided.

In a first aspect, the present invention provides a test device for detecting an analyte suspected of being present in a fluid sample. The device has a casing, having a port for a sample collection well. The device further contains a test compartment containing at least one test element. The sample collection well is situated in the port, and has an expression plate, and a plunger having a raised position and a lower position. The device also has a chamber for storage of a confirmation sample. A lance is also contained within the device, and in one embodiment is carried by the plunger. The device also has a sample outlet sealed by a frangible material that provides liquid communication between the sample collection well and the test compartment when the sample outlet is open. The device also has a mp for the sample collection well, where a portion of the cap interacts with the plunger to move the plunger from the raised position to the lower position when the cap is applied to the sample collection well.

The term “plunger” refers to a part of the device that moves through a portion of the device to bring two parts into contact and perform a function in the operation of the device. In one embodiment the plunger moves within a circular or cylindrical part of the device. In some embodiments the plunger carries a lance and serves to deliver the lance to a frangible material that is pierced by the lance. A “lance” is an object that pierces a frangible seal. The lance will typically be sharp or otherwise have the capability to pierce the frangible seal. The “port” is a portion of the device where the casing interfaces with the sample collection well. The port can be an opening into which the sample collection well fits reversibly, or the sample collection well and casing can be produced as a single unit. The port also provides access between the sample collection well and the test compartment.

An “expression plate” refers to a surface where a sample applicator filled with fluid sample can be squeezed or crushed against to express sample from the applicator. The expression plate can have openings or holes to allow the passage of fluid sample from the applicator to the sample collection well. The expression plate can be located within the sample collection well, but can also be placed in another location where expressed sample will flow to the collection well. In one embodiment the expression plate is located in the sample collection well and divides the upper and lower chambers, and has one or more holes or openings through which fluid sample can flow from the upper chamber to the lower chamber. When the sample collector is pressed against the expression plate, sample flows through the opening in the expression plate, into the lower chamber.

The “test element” can be any element that performs a test. In one embodiment, the test element is a test strip. The test strip may contain a member of a specific binding pair on the test strip for conducting an immunoassay. The test strip may be a chemical test strip that provides a detectable color change or other detectable signal when the assay is complete. A variety of samples can be used with the present invention including, but not limited to, a bodily fluid or a sample derived from a biological tissue or a bodily fluid. For example, the sample may be saliva, blood, serum, plasma, urine, feces, spinal fluid, vaginal swabs, mucus, and tissue. In one embodiment, the expression plate divides the upper chamber from the lower chamber, and has an aperture for flow of liquid sample from the upper chamber to the lower chamber.

The “sample outlet” provides liquid communication from the sample collection well to the test compartment. The sample outlet in the device is sealed by a frangible material, and liquid communication does not occur between the sample collection well and test compartment until the frangible seal is pierced or broken by the lance, which is lowered into the frangible material by the plunger to begin the assay.

In one embodiment the sample collection well also has a lower chamber present when the plunger is in the raised position, and an upper chamber where the confirmation sample is stored. In one embodiment the sample collection well contains the plunger, upper and lower chambers, the expression plate, and the sample outlet, however, in other embodiments these components can be located outside the sample collection well. In one embodiment, expression plate divides the upper chamber from the lower chamber, and has an aperture for flow of liquid sample from the upper chamber to the lower chamber. The lance can be carried on the plunger (e.g., on the bottom surface of the plunger), and can be downwardly-projecting and perpendicularly aligned with the sample outlet for breaking the frangible material. The sample collection well and cap can have complementary engaging screw threads. In one embodiment the cap carries a downward projection that interacts with the plunger when the cap is applied to the sample collection well. The expression plate can have an opening through which the projection passes to interact with (and push) the plunger. By “complementary engaging screw threads” is meant that the cap and sample collection well each have screw threads which are complementary and the cap can be screwed onto the sample collection well to obtain a fit by rotation of the cap on the sample collection well and engagement of the screw threads, and where liquid sample does not leak from around the cap.

In certain embodiments of the present invention, the lower chamber is absent when the plunger is in the lower position. This can be due to the lower chamber existing under the plunger, and disappearing when the plunger is lowered and the lance pierces the frangible material. The frangible material can be any material that is pierceable by a lance. Examples of frangible materials include (but are not limited to) paper, wax-coated paper, plastic-coated paper, plastic film, a thin plastic sheet, adhesive tape, foil, waxed foil and plastic-coated foil.

In some embodiments, the test element is a test strip. The test strip may have specific binding molecules immobilized on the test strip, but can also have a chemical test. The fluid sample can be any fluid such as (for example) oral fluid, saliva, blood, serum, plasma, urine, feces, spinal fluid, vaginal swabs, mucus, and tissue. “Saliva” refers to the excretions of the salivary glands. “Oral fluid” is any fluid present in the buccal cavity and saliva is a major component of oral fluid. Any analyte can be detected using the present invention for which a test element exists. For example, the analyte can be a drug (such as a drug of abuse), a hormone, a protein, a peptide, a nucleic acid molecule, an etiological agent and a specific binding pair member. In a further embodiment, the upper and lower chambers are present in the sample collection well when the plunger is in the raised position, and the lower chamber is not present when the plunger is in the lower position. In another embodiment the sample collection well is sealed when the lance punctures the frangible material. The sample collection well can be sealed by seals present on the lower portion of the plunger and/or seals located at or around the reservoir. Thus, when the plunger is lowered the sealing bodies provide a seal to the sample collection well.

In another aspect, the present invention provides a kit having a device described herein, and a sample applicator. In one embodiment of the present invention, the sample applicator has an absorbent member and a handle. The absorbent member may be a sponge, a foam, or any material that absorbs liquid. The absorbent member can be soaked in or pre-treated with a solution that stimulates salivation in a test subject. The kit can also contain instructions for use of the device. In one embodiment the instructions are for use of the device for the detection of an analyte in a fluid sample.

In another aspect the present invention provides methods of detecting the presence of an analyte in a fluid sample. The methods involve applying the fluid sample to a device as described herein, applying the cap to the sample collection well, engaging the plunger and lowering the plunger so that the lance punctures the frangible material and releases the fluid sample into the test compartment, and determining the presence of the analyte in the fluid sample. In certain embodiments, applying the sample includes contacting a sample applicator with the fluid sample, inserting the sample applicator into the sample well, and pressing the sample applicator against the expression plate to express the fluid sample into the sample collection well. The expressed fluid sample flows into the lower chamber of the sample collection well and a portion of the fluid flows from the upper chamber around at least one edge of the plunger and into the lower chamber.

In another embodiment of the present method, after fluid sample is applied to the sample collection well, the cap is applied to the sample collection well and the plunger is lowered to puncture the frangible material as the cap is applied, thereby providing fluid communication between the sample collection well and the test compartment. In certain embodiments, the fluid sample flows from the lower chamber to the test compartment when the plunger punctures the frangible material. The sample collection well and cap can further comprise complementary engaging screw threads. When the cap is screwed onto the sample collection well, a portion of the cap interacts to provide a force onto the plunger and thereby lower the plunger and puncture the frangible material. In one embodiment, the lower chamber is not present when the plunger is in the lower position. The force applied to the plunger may be a direct force from the bottom of the cap to the back of the plunger.

The summary of the invention described above is not limiting and other features and advantages of the invention will be apparent from the following detailed description, as well as from the claims.

FIG. 1 provides a perspective view of one embodiment of the present invention.

FIG. 2 provides an exploded view of the device shown in FIG. 1.

FIG. 3 provides a cut-away view of the device shown in FIG. 1.

FIG. 4 provides a cut-away view and a magnified view of the device shown in FIG. 1, during use.

FIG. 5 provides a cut-away view and a magnified view of the device shown in FIG. 1, after use. Note the lance is shown having pierced the frangible material.

FIG. 6 provides a top view and a section view of the device shown in FIG. 1, after use.

In the following detailed description, reference is made to the accompanying drawings that form a part hereof, and in which is shown by way of illustration specific embodiments in which the invention may be practiced. It is understood that other embodiments may be utilized and structural changes may be made without departing from the scope of the present invention.

The devices and methods of the present invention enable the easy detection of analytes in fluid samples. The devices also allow a quantity of sample to be easily stored for confirmatory testing later in a reservoir within the device, using a different principle of testing if desired. The confirmation sample is therefore safely stored from contamination. The device also allows the user to control the time of beginning the assay, because the user can apply sample to the sample collection well and fill the sample collection well, but the assay will not begin until the user applies the cap to the sample collection well and lowers the plunger, thereby puncturing the frangible material and releasing the fluid sample into the test compartment. FIGS. 1-6 show only certain embodiments of the present invention for purposes of illustrating the invention, and are not limiting. With reference to the present disclosure the person of ordinary skill will realize other embodiments.

Sample Analysis and Storage Device

The present invention provides a test device for detecting an analyte in a fluid sample, and for storing an aliquot of the sample for confirmation testing. FIGS. 1-6 show one embodiment of the present device 100, which comprises a casing 110, having an injection molded top 210 and base 215. The casing has a test compartment 360 in which are situated test elements for conducting the assay of the invention. There is also a port 120 in which is situated a sample collection well 130. In one embodiment the sample collection has a plunger 240, an upper chamber 320 for storage of a confirmation sample, an expression plate 230 for expressing sample from a sample applicator by wringing or squeezing against the expression plate, a sample outlet 350 sealed by a frangible material 270 and which provides liquid communication between the sample collection well and the test compartment when the sample outlet is open. In other embodiments these components may not be present in the sample collection well. In the embodiment illustrated in FIGS. 4 though 6, the expression plate divides the upper chamber from the lower chamber, and has an aperture 520 for flow of liquid sample from the upper chamber to the lower chamber. Additionally, the plunger has both raised and lowered positions. When the plunger is in the raised position a lower chamber 330 is present in the sample collection well (see FIGS. 3 and 4). When the plunger is in the lowered position, the lower chamber is no longer present (see FIGS. 5 and 6). In other words, the lower chamber disappears when the plunger moves into the lowered position as the space then becomes occupied by the plunger.

Embodiments of the device are possible where no upper and lower chambers are present, but a single chamber performs the functions. The expression plate can also be located at a point removed from the sample collection well, and the fluid sample transferred to the test compartment. Also, the lance can be carried on the plunger, which can be present in the sample collection well (as shown in the Figures), but the lance can also be present as a separate component, either within or outside of the sample collection well.

The plunger maybe made of a variety of materials, such as injection-molded or press-molded plastic. The plunger has a face, which is the portion opposite the cap and closest to the sample outlet, and a back which is the portion of the plunger body closest to the cap. The plunger can carry the lance on its face side. The plunger can also have arms which extend towards the cap, so that the bottom of the cap interfaces with the plunger arms to apply force on the plunger and drive it and the lance into the frangible material. The lance is sufficiently sharp and hard to break the fungible material that has been chosen to cover the sample outlet. The lance can be manufactured as an integral part of the injection-molded plastic plunger, or incorporated into the plastic plunger.

In one embodiment, the device has a cap 220 for the sample collection well (see FIGS. 2, 5 and 6). In one embodiment the sample collection well and cap have complementary engaging screw threads. The cap can have a projection 510 (see FIGS. 5 and 6) that interacts with the plunger, such as a downward projection from the bottom of the cap. The projection can be an extended projection from the center bottom of the cap, but in other embodiments it can be arms extending from the center or sides of the cap, or other projections that extend from the cap and interact directly or indirectly with the plunger. The expression plate has an opening 520 through which the projection passes to interact with the plunger. When the cap is screwed onto the sample collection well, the downward projection of the cap is placed into contact with the plunger and moves it from the raised position to the lowered position. This causes the lower chamber to disappear.

In certain embodiments, the plunger carries a lance 340 on its bottom surface. The lance on the bottom of the plunger can be downwardly-projecting towards the sample outlet, and is aligned with the outlet for breaking the frangible material. In one embodiment the plunger is perpendicularly aligned with the plane of the outlet. As the plunger is moved to its lower position, the lance moves into and punctures the frangible material, and sample in the sample collection well (e.g., from the lower chamber) flows into the test compartment. The frangible material may be made of any convenient material, such as paper, wax-coated paper, plastic-coated paper, plastic film, a thin plastic sheet, adhesive tape, foil, waxed foil and plastic-coated foil. The frangible material may be attached with adhesive.

In one embodiment the lance can also have affixed to its lower edge a seal, so that when the plunger is in the lower position a seal is effected between the sample collection well and the test compartment. The seal can be made of rubber, plastic, or any material that can form a seal over the outlet when the plunger is in the lower position.

As shown in FIGS. 2, 3, 4 and 5, an O-ring 380 is provided around the rim of the plunger. However, any sealing mechanism can also be used. FIG. 4 illustrates a conical shoulder 420 on the wall of the of the sample collection well. In one embodiment, the diameter of the collection well above the shoulder is slightly wider than the diameter of the lower chamber. The plunger is sized to fit snugly into the diameter of the lower chamber and against the bottom of the lower chamber, such that the O-ring and plunger create a seal between the sample collection well and the test compartment. Thus, the sample collection well becomes a reservoir for the sample remaining in the collection well, and which can be preserved in the device and used for confirmation testing. When the plunger is in the raised position, the plunger fits loosely within the diameter of the sample collection well, leaving a small space 430 between the edge of the plunger and the wall of the sample application well, through which a portion of fluid sample flows into the lower chamber. Sample can also flow through openings which exist in some embodiments in the plunger and/or expression plate. The plunger can also have a seal on its face so that when the plunger pierces the frangible material, the plunger continues forward until it mates with the bottom of the sample collection well, forming a seal between the sides of the plunger and the walls of the sample collection well lower chamber, as well as a seal being formed around the sample outlet. Thus, the plunger can carry an O-ring or other type of seal on its face for this purpose. It can also be arranged so that a seal exists on the bottom of the lower chamber of the sample collection well, and that this component forms a seal to close the sample outlet when the plunger in the lower position.

In another embodiment of the present device, the test compartment contains at least one test element 280, for example, a test strip. A variety of analyte test strips can be incorporated into the present invention which is discussed in greater detail below. Sample comes into contact with the test strips when the plunger has been pushed into the lowered position and the frangible seal is broken. When the frangible seal breaks, sample that is present in the lower chamber flows through the sample outlet and contacts the wicking paper 260. The wicking paper moves the sample by capillary action to the sample loading end of the test strips (see below) and the tests are initiated. While the illustrated embodiments use wicking paper, it is also possible to not use wicking paper and allow the sample to flow directly to the test element. The test results can be read through a window 370 provided in the top of the casing. Indicia may be provided next to the window, to indicate to the user where to expect test result lines and control lines.

Sample Applicator

A sample applicator may be supplied with the device of the present invention. In one embodiment the sample applicator has an absorbent member 140 and a handle 144. The absorbent member can be made of medical grade sponge or foam material commonly used in the art. But many other materials are available for use as an absorbent member, such as cotton or paper, or any material having suitable absorbent capacity. The handle is generally rigid, to facilitate manipulation of the absorbent member. The handle may be made of any material commonly employed in the art, such as plastic, wood, metal or cardboard. In one embodiment the handle has a rim 142 (FIG. 1) to which the absorbent member is attached. In some embodiments the absorbent member is soaked in or pre-treated with a material that stimulates salivation in the test subject.

In some embodiments of the present invention, the upper chamber of the sample application well may have ribs. The sample applicator can be adapted so that its rim locks under the ribs when the applicator has been sufficiently pressed against the expression plate and then twisted to fit under the ribs. This may ensure that the absorbent member of the applicator has been sufficiently squeezed for a sufficient amount of time to express as much sample contained therein as possible.

Test Strips

A variety of test elements can be incorporated into the present invention. One type of test element is a test strip. Analyte test strips are test elements provided in a variety of formats, such as immunoassay or chemical test format, for detecting analytes of interest in a sample, such as a drug of abuse or a metabolite suggestive of health status. Test strips can also be provided in either noncompetitive or competitive assay formats. In some formats, the test strips have a bibulous material having a sample application zone, a reagent zone and a test result zone. The sample is applied to the sample application zone and flows into the reagent zone by capillary action. In the reagent zone, the sample dissolves and mixes with reagents necessary for detection of the analyte (if it is present in the sample). The sample, now carrying the reagents, continues to flow to the test results zone. Additional reagents are immobilized in the test results zone, such as a specific binding molecule for the analyte. These reagents react with and bind the analyte (if present) or one of the first reagents from the reagent zone. Labels for forming the detectable signal can be present in the reagent zone, or a separate label zone.

In noncompetitive formats, a signal is produced if the sample contains the analyte, and no signal is produced if the analyte is not present. In competitive formats, a signal can be produced if no analyte is present, and no signal if analyte is present.

When the test element is a test strip, it may be made of bibulous or non-bibulous material. A test strip can include more than one material, which are then in fluid communication. One material of a test strip may be overlaid on another material of the test strip, such as for example, filter paper overlaid on nitrocellulose. Alternatively or in addition, a test strip may include a region comprising one or more materials followed by a region comprising one or more different materials. In this case, the regions are in fluid communication and may or may not partially overlap one another. The material or materials of the test strip can be bound to a support or solid surface such as a supporting sheet of plastic, to increase its handling strength.

In embodiments where the analyte is detected by a signal producing system, such as by one or more enzymes that specifically react with the analyte, one or more components of the signal producing system can be bound to the analyte detection zone of the test strip material in the same manner as specific binding members are bound to the test strip material, as described above. Alternatively or in addition, components of the signal producing system that are included in the sample application zone, the reagent zone, or the analyte detection zone of the test strip, or that are included throughout the test strip, may be impregnated into one or more materials of the test strip. This can be achieved either by surface application of solutions of such components or by immersion of the one or more test strip materials into solutions of such components. Following one or more applications or one or more immersions, the test strip material is dried. Alternatively or in addition, components of the signal producing system that are included in the sample application zone, the reagent zone, or the analyte detection zone of the test strip, or that are included throughout the test strip, may be applied to the surface of one or more test strip materials of the test strip as was described for labeled reagents.

The zones can be arranged as follows: sample application zone, one or more reagent zones, one or more test results determination zones, one or more control zones, one or more adulteration zones, and fluid absorbing zone. If the test results determination zone includes a control zone, preferably it follows the analyte detection zone of the test result determination zone. All of these zones, or combinations thereof, can be provided in a single strip of a single material. Alternatively, the zones are made of different materials and are linked together in fluid communication. For example, the different zones can be in direct or indirect fluid communication. In this instance, the different zones can be jointed end-to-end to be in fluid communication, overlapped to be in fluid communication, or be communicated by another member, such a joining material, which is preferably bibulous such as filter paper, fiberglass or nitrocellulose. In using a joining material, a joining material may communicate fluid from end-to-end joined zones or materials including such zones, end-to-end joined zones or materials including such zones that are not in fluid communication, or join zones or materials that include such zones that are overlapped (such as but not limited to from top to bottom) but not in fluid communication.

When and if a test strip includes an adulteration control zone, the adulteration control zone can be placed before or after the results determination zone. When a control zone is present in the results determination zone on such a test strip, then the adulteration control zone is preferably before the control zone, but that need not be the case. In the embodiment of the present invention where a test strip is a control test strip for the determination of an adulteration analyte and/or a control, then the adulteration control zone can be placed before or after the control zone, but is preferably before the control zone. The reagents used in the adulteration assay determine whether there has been an attempt to defeat the purpose of the assay by the test subject, such as by adding material to the sample to change the results of the assay.

Samples that can be tested with the device of the present invention include liquids of biological origin (e.g., casing fluids and clinical samples). Liquid samples may be derived from solid or semi-solid samples, including feces, biological tissue, and food samples. Such solid or semi-solid samples can be converted into a liquid sample by any suitable method, for example by mixing, chopping, macerating, incubating, dissolving or enzymatically digesting solid samples in a suitable liquid (e.g., water, phosphate-buffered saline, or other buffers). “Biological samples” include samples derived from living animals, plants, and food, including for example urine, saliva, blood and blood components, cerebrospinal fluid, vaginal swabs, semen, feces, sweat, exudates, tissue, organs, tumors, tissue and organ culture, cell cultures and conditioned media therefrom, whether from humans or animals. A preferred biological sample is urine. Food samples include samples from processed food components or final products, meat, cheese, wine, milk and drinking water. Plant samples include those derived from any plant, plant tissue, plant cell cultures and conditioned media therefrom. “Environmental samples” are those derived from the environment (e.g., a water sample from a lake or other casing of water, effluent samples, soil samples, ground water, ocean water, and runoff water. Sewage and related wastes can also be included as environmental samples.

Any analyte can be tested for utilizing the present invention and a suitable test element. In particular, the present invention can be utilized for the detection of a drug of abuse in oral fluid. A “drug of abuse” (DOA) is a drug that is taken for non-medicinal reasons (usually for mind-altering effects). The abuse of such drugs can lead to physical and mental damage and (with some substances) dependence, addiction and/or death. Examples of DOAs include cocaine; amphetamines (e.g., black beauties, white bennies, dextroamphetamines, dexies, beans); methamphetamines (crank, meth, crystal, speed); barbiturates (Valium®, Roche Pharmaceuticals, Nutley, N.J.); sedatives (i.e. sleep-aids); lysergic acid diethylamide (LSD); depressants (downers, goofballs, barbs, blue devils, yellow jackets, ludes); tricyclic antidepressants (TCA, e.g., imipramine, amitriptyline and doxepin); phencyclidine (PCP); tetrahydrocannabinol (THC, pot, dope, hash, weed, etc.); and opiates (e.g., morphine, opium, codeine, heroin, oxycodone).

Additional analytes that can be tested using the present invention include but are not limited to creatinine, bilirubin, nitrite, protein (nonspecific), hormones (e.g. human chorionic gonadotropin, luteinizing hormone, follicle stimulating hormone, etc.), blood, leukocytes, sugar, heavy metals or toxins, bacterial components (e.g. proteins or sugars specific to a particular type of bacteria, such as E. coli0157:H7, S. aureus, Salmonella, C. perfringens, Carnpylobacter, L. monocytogenes, V. parahaemolyticus, or B. cereus) and physical characteristics of the urine sample, such as pH and specific gravity. Any other clinical urine chemistry analyte that can be adapted to a lateral flow test format may also be incorporated into the present device.

Methods of Use

The following discussion relates to those embodiments illustrated in the examples. Of course other embodiments are possible without departing from the scope of this invention. In the methods of the invention, the step of applying the sample to the device can include contacting a sample applicator with the fluid sample, for example, by inserting it into the mouth of a test subject or by immersing it in a container of fluid sample. The filled or soaked applicator 144 can be inserted into the sample collection well 130, and the applicator pressed or squeezed against the expression plate 230 to express the fluid sample into the sample collection well (see FIG. 4). The expressed fluid sample flows into the lower chamber of the sample collection well through openings in the expression plate, or through spaces 430 present at the sides of the plunger 240 (FIG. 3). Thus, a portion of the fluid flows from the upper chamber around an edge of the plunger and into the lower chamber 330.

After sample is completely expressed, the cap 220 can be applied to the sample collection well (see FIGS. 2 and 5). When the cap and sample collection cup contain complementary engaging screw threads, the cap is screwed onto the sample collection well. The cap can contain a part or projection that interacts with the plunger. For example, the center bottom of the cap can contain a projection that extends downward through the center of the expression plate and is therefore placed on the back of the plunger to exert the force. The interaction can be simply the physical contact and transfer of force to the plunger applied by the downward motion of the cap. This force causes the plunger to be lowered within the sample collection cup as the cap is screwed on, and for the lance carried on the plunger to be lowered into the frangible material, and thereby puncture it. Thus, fluid communication is provided between the sample collection well and the test compartment. Fluid then flows from the sample collection well to the test compartment, and the assaying begins. In other embodiments, the cap can be snapped onto the top of the sample collection well, or otherwise applied so that sample does not leak out, and force is applied to the plunger. FIG. 5 shows the plunger in the lowered position and that the lance has punctured the frangible material, thereby opening the sample outlet. The Figures also show an absorbent wicking paper 260 placed below the sample outlet, which can be used to enhance flow of the fluid sample from the sample collection well to the test elements. The wicking paper can be made of any convenient bibulous material capable of capillary flow. Examples include glass fiber paper and polyester mesh treated to become hydrophilic and filter paper. After the control indicia are provided, the result of the assay is conveniently determined by viewing the test element through the window 370.

Test Kits

Test kits of the invention can be packaged in a variety of formats, depending upon the Customer's needs. For example, a facility that conducts large numbers of pre-employment drug screenings may prefer boxes of 1 set of instructions plus 20 vacuum packed set of devices and applicators. On the other hand, other users may prefer boxed kits that contain only one device, one sample collector, and one set of instructions. Any suitable packaging materials can be used. Test kits may be packaged in a box, or may be wrapped in protective material such as cellophane. Test kits may also be provided with a test device (and applicator) provided in the same or separate sealed pouches, which may or may not then be provided in a box or other packaging.

The devices of the invention can be utilized in a variety of contexts. This example illustrates a use of the device for pre-employment drug screening. The person to be tested provides a sample of saliva by placing the sample applicator into his or her mouth, and allowing it to remain in the mouth for about 5 minutes. In embodiments for pre-employment drug screening the device contains lest strips for several common drugs of abuse, in this embodiment cocaine, methamphetamine, phencyclidine, THC, morphine, and amphetamines. The device utilizes test strips in a competitive immunoassay format where labeled specific binding molecules (antibodies labeled with gold sol in this embodiment) for each drug being tested are present on the label zone of the test strip. The test lines contain the antigen being tested for. If analyte is present in the sample it is bound by labeled specific binding molecules in the label zone, thereby preventing the labeled antibody from binding to the test line. Thus, no signal occurs on the test line when analyte is present. Conversely, when no antigen is present in the sample, the labeled antibodies bind to the test line providing the signal on the test line.

After receiving the filled or soaked sample applicator, the testing technician inserts it into the sample collection well of the device. The technician presses the applicator down into the well and then twists it, to lock the rim of the applicator under a pair a flanges 410 (provided in this embodiment). Saliva is thereby expressed from the absorbent foam of the sample applicator and flows through the orifice in the expression plate and into the chamber below the expression plate. Since the plunger is in the first position, some of the sample flows around the edges of the plunger into the lower chamber of the sample collection well. When all sample is expressed from the foam, the applicator is removed and the cap is screwed onto the sample collection well. As the cap is screwed onto the sample collection well, the downward projection of the cap pushes the plunger from the raised position to the lowered position, thereby driving the lance into the frangible seal, breaking the seal, and opening the sample outlet. Sample then flows into the test compartment, where it comes into contact with the test strips. At the same time, the portion of the sample remaining in the upper chamber, above the plunger is isolated from the rest of the apparatus, because the plunger becomes a seal between the upper chamber and the test compartment and thereby creating a reservoir to hold the remaining sample. After a few minutes, the control indicia are provided on the test elements, indicating that the assay is complete. A signal is provided at each of the test lines, indicating that no drugs of abuse are present in the saliva sample (competitive assay format). If a positive result is determined, the device may be sent to a confirmatory laboratory so that the sample contained in the reservoir can be tested to confirm the result.

With reference to the present disclosure the person of ordinary skill in the art will realize that any analyte for which a test element is available or later developed can be used in the present invention. Thus, any other drugs of abuse of interest can be tested for, and several example are listed herein. Similarly, any analyte from any sample type can be tested for.

The invention illustratively described herein may be practiced in the absence of any element or elements, limitation or limitations that are not specifically disclosed herein. The terms and expressions which have been employed are used as terms of description and not of limitation, and there is no intention that in the use of such terms and expressions of excluding any equivalents of the features shown and described or portions thereof, but it is recognized that various modifications are possible within the scope of the invention claimed. Thus, it should be understood that although the present invention has been specifically disclosed by various embodiments and optional features, modification and variation of the concepts herein disclosed may be resorted to by those skilled in the art, and that such modifications and variations are considered to be within the scope of this invention as defined by the appended claims.

The contents of the articles, patents, and patent applications, and all other documents and electronically available information mentioned or cited herein, are hereby incorporated by reference in their entirety to the same extent as if each individual publication was specifically and individually indicated to be incorporated by reference. Applicants reserve the right to physically incorporate into this application any and all materials and information from any such articles, patents, patent applications, or other documents.

Yang, Ying, Wu, Yuzhang, Tung, Hsiaoho E., Dai, Jeilin

Patent Priority Assignee Title
10052629, Dec 31 2014 VISBY MEDICAL, INC Devices and methods for molecular diagnostic testing
10073069, Apr 23 2013 APOGEM CAPITAL LLC Systems and methods to determine body drug concentration from an oral fluid
10112196, Dec 31 2014 VISBY MEDICAL, INC Devices and methods for molecular diagnostic testing
10112197, Dec 31 2014 VISBY MEDICAL, INC Devices and methods for molecular diagnostic testing
10124334, Dec 31 2014 VISBY MEDICAL, INC Devices and methods for molecular diagnostic testing
10195610, Mar 10 2014 VISBY MEDICAL, INC Cartridge-based thermocycler
10279346, Dec 31 2014 VISBY MEDICAL, INC Devices and methods for molecular diagnostic testing
10456783, Dec 31 2014 VISBY MEDICAL, INC Devices and methods for molecular diagnostic testing
10525469, Dec 31 2014 VISBY MEDICAL, INC Devices and methods for molecular diagnostic testing
10549272, Oct 23 2007 Becton, Dickinson and Company Tissue container for molecular and histology diagnostics incorporating a breakable membrane
10639636, Oct 23 2007 Becton, Dickinson and Company Closed kit for tissue containment and stabilization for molecular and histopathology diagnostics
10656059, Mar 07 2018 ALCALA PHARMACEUTICAL, INC.; ALCALA PHARMACEUTICAL, INC Method for qualitative and quantitative multiplexing of drug analytes from biological samples
10660619, Jul 19 2017 ASPIDA DX INC Cartridges for oral fluid analysis and methods of use
10675623, Jun 29 2016 VISBY MEDICAL, INC Devices and methods for the detection of molecules using a flow cell
10744507, Nov 13 2012 PREMIER BIOTECH, LLC Screening device for analysis of bodily fluids
10960399, Mar 10 2014 VISBY MEDICAL, INC Cartridge-based thermocycler
10987674, Apr 22 2016 VISBY MEDICAL, INC Printed circuit board heater for an amplification module
11054349, Mar 07 2018 ALCALA PHARMACEUTICAL, INC. Method for preparation of dried blood sample for multiplexing of analytes
11112405, May 18 2020 BASELINE BIOSCIENCE, INC Assay device, system, method, and kit
11123167, Jul 28 2010 JOHNSON & JOHNSON CONSUMER INC Methods for providing beneficial effects to the oral cavity
11135043, Oct 18 2017 JOHNSON & JOHNSON CONSUMER INC Methods for providing beneficial effects to the oral cavity
11162130, Nov 09 2017 VISBY MEDICAL, INC Portable molecular diagnostic device and methods for the detection of target viruses
11167285, Dec 31 2014 VISBY MEDICAL, INC Devices and methods for molecular diagnostic testing
11168354, Nov 09 2017 Visby Medical, Inc. Portable molecular diagnostic device and methods for the detection of target viruses
11193119, May 11 2016 VISBY MEDICAL, INC Devices and methods for nucleic acid extraction
11199529, Sep 21 2017 Becton, Dickinson and Company Hazardous contaminant collection kit and rapid testing
11262367, Dec 15 2017 ASPIDA DX INC Optical reader for analyte testing
11273443, Dec 31 2014 Visby Medical, Inc. Devices and methods for molecular diagnostic testing
11278889, Jul 18 2017 Hewlett-Packard Development Company, L.P. Test sample devices and methods
11280801, Jan 28 2019 Becton, Dickinson and Company Hazardous contaminant collection device with integrated swab and test device
11360001, Sep 21 2017 Becton, Dickinson and Company Reactive demarcation template for hazardous contaminant testing
11380074, Sep 21 2017 Becton, Dickinson and Company Augmented reality devices for hazardous contaminant testing
11385146, Sep 21 2017 Becton, Dickinson and Company Sampling systems and techniques to collect hazardous contaminants with high pickup and shedding efficiencies
11391748, Sep 21 2017 Becton, Dickinson and Company High dynamic range assays in hazardous contaminant testing
11529633, Apr 22 2016 Visby Medical, Inc. Printed circuit board heater for an amplification module
11577238, Mar 02 2017 HERO SCIENTIFIC LTD Testing for particulates
11585733, Sep 21 2017 Becton, Dickinson and Company Hazardous contaminant collection kit and rapid testing
11622751, Dec 19 2018 JOHNSON & JOHNSON CONSUMER INC Devices and methods for collecting saliva samples from the oral cavity
11680877, Sep 05 2018 HERO SCIENTIFIC LTD Testing for particulates
11759783, Nov 26 2015 NOVAMED LTD Assay device
11782042, Sep 21 2017 Becton, Dickinson and Company Hazardous contaminant collection kit and rapid testing
11821819, Sep 21 2017 Becton, Dickinson and Company Demarcation template for hazardous contaminant testing
11860173, Jan 28 2019 Becton, Dickinson and Company Hazardous contaminant collection device with integrated swab and test device
11885722, Jan 06 2021 HERO SCIENTIFIC LTD Filtration sampling devices
11890614, Mar 02 2017 HERO SCIENTIFIC LTD. Testing for particulates
11890615, Mar 02 2017 HERO SCIENTIFIC LTD. Testing for particulates
11921018, Jan 06 2021 HERO SCIENTIFIC LTD Filtration sampling devices
11940454, Dec 15 2017 ASPIDA DX INC Optical reader for analyte testing
8257329, Aug 24 2009 Contraband retrieval device
8514067, Aug 16 2011 Elwha LLC Systematic distillation of status data relating to regimen compliance
8599009, Aug 16 2011 Elwha LLC Systematic distillation of status data relating to regimen compliance
8723640, Aug 16 2011 Elwha LLC Distillation of status data relating to regimen compliance responsive to the presence and absence of wireless signals relating to one or more threshold frequencies
8816814, Aug 16 2011 Elwha LLC Systematic distillation of status data responsive to whether or not a wireless signal has been received and relating to regimen compliance
9091680, May 20 2014 Fecal occult blood testing system
9110053, Aug 20 2010 Agilent Technologies Inc Dried blood spotting paper device and method
9308064, Jul 26 2010 JOHNSON & JOHNSON CONSUMER INC Devices and methods for collecting and analyzing fluid samples from the oral cavity
9468925, Oct 23 2007 Becton, Dickinson and Company Tissue container for molecular and histology diagnostics incorporating a breakable membrane
9623415, Dec 31 2014 VISBY MEDICAL, INC Devices and methods for molecular diagnostic testing
9770189, Aug 16 2011 Elwha LLC Systematic distillation of status data relating to regimen compliance
9927433, Aug 20 2014 SHIN CORPORATION Test apparatus
9968335, Jul 26 2010 JOHNSON & JOHNSON CONSUMER INC Devices and methods for collecting and analyzing fluid samples from the oral cavity
D706945, Jul 02 2013 MedMira Inc. Diagnostic device
D720468, Jan 28 2013 Advanced Animal Diagnostics Sample collection device assembly
D800331, Jun 29 2016 VISBY MEDICAL, INC Molecular diagnostic device
D800913, Jun 30 2016 VISBY MEDICAL, INC Detection window for molecular diagnostic device
D800914, Jun 30 2016 VISBY MEDICAL, INC Status indicator for molecular diagnostic device
D923195, Sep 21 2017 Becton, Dickinson and Company Collection device
D976437, Sep 21 2017 Becton, Dickinson and Company Collection device
Patent Priority Assignee Title
3896974,
4014748, Dec 22 1975 Cassella Aktiengesellschaft Anaerobic culture collecting and transporting apparatus
4114605, Nov 02 1976 UAB RESEARCH FOUNDATION, THE, NON-PROFIT CORP Intraoral cup for collecting saliva and method of using the same
4275149, Nov 24 1978 Dade Behring Marburg GmbH Macromolecular environment control in specific receptor assays
4299916, Dec 26 1979 Dade Behring Marburg GmbH Preferential signal production on a surface in immunoassays
4458020, Nov 15 1982 QUIDEL CORPORATION, 11077 NORTH TORREY PINES ROAD, LA JOLLA, CA 92037, A CORP OF DE Integrated single tube plunger immunoassay system having plural reagent chambers
4635488, Dec 03 1984 Schleicher & Schuell, Inc. Nonintrusive body fluid samplers and methods of using same
4768238, May 04 1987 Interstate Drug Exchange Bifurcated saliva collector
4771486, Dec 07 1987 Sputum specimen collecting device
4817632, Jun 23 1987 PBI TECHNOLOGY, INC Oral fluid collection article
4853325, Mar 26 1986 Synbiotics Corporation Saliva test for feline leukemia virus
4857453, Apr 07 1987 Dade Behring Marburg GmbH Immunoassay device
4877850, Feb 22 1988 Kureha Kagaku Kogyo Kabushiki Kaisha Buffer wash of polyarylene sulfides
4886175, Apr 10 1989 Merck & Co., Inc. Bottle and cap closure system
4923798, Mar 26 1986 SYNBIOTICS CORPORATION, 11011 VIA FRONTERA, SAN DIEGO, CALIFORNIA 92127 A CORP OF CA Saliva test for feline leukemia virus
4955745, Oct 05 1989 Bottle with applicator
4962025, Jan 02 1986 ALCOPRO, INC Reagent alcohol test strip device
5050616, Mar 14 1990 UNITED STATES OF AMERICA, THE, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Universal collector for submandibular-sublingual saliva
5073484, Mar 09 1982 Surmodics, Inc Quantitative analysis apparatus and method
5076474, Oct 23 1987 Dropper bottle with frangible outlet element
5119831, Jan 11 1991 University of Iowa Research Foundation System and method for detecting pressure of selected body parts
5160329, Apr 13 1990 T SYSTEMS INC Biological fluid specimen collection bag
5170799, Feb 20 1988 Showa Yakuhin Kako Co., Ltd. Test strip for measuring tear production
5185127, Sep 21 1989 Becton, Dickinson and Company Test device including flow control means
5186900, Aug 26 1987 FORENSIC TECHNOLOGIES, INC Blood collection and transportation assembly for evidentiary purposes
5211182, Oct 23 1991 Home ovulation test kit and method
5234001, Sep 21 1989 ORASURE TECHNOLOGIES, INC Container for immunoassay with frangible nipple
5246145, May 03 1990 Nalge Nunc International Corporation Liquid dropper spout having lockable pivoted closure cap
5252496, Dec 18 1989 PBM-SELFCARE, LLC Carbon black immunochemical label
5260031, Dec 18 1990 HOME ACCESS HEALTH CORPORATIN Saliva sampling device with sample adequacy indicating system
5261572, Jun 09 1992 TECH SPRAY, L P Dropper bottle
5275785, Oct 30 1987 Inverness Medical Switzerland GmbH Test device for detecting an analyte in a liquid sample
5328058, May 03 1990 AVENTIS PHARMA S A Dropper bottle assembly with squeeze cap
5334502, Nov 27 1991 LABONE, INC Method of collecting, identifying, and quantifying saliva
5339829, Sep 21 1989 ORASURE TECHNOLOGIES, INC Oral collection device
5352410, Jun 03 1993 Fluid specimen collection and testing apparatus
5376337, Dec 18 1990 Saliva sampling device and sample adequacy system
5380492, Dec 18 1990 Sampling device and sample adequacy system
5393496, Dec 18 1990 SALIVA DIAGNOSTIC SYSTEMS, INC Saliva sampling device and sample adequacy system
5415994, Aug 02 1993 Quidel Corporation Lateral flow medical diagnostic assay device with sample extraction means
5416000, Jun 22 1987 CHEMTRAK, INC Analyte immunoassay in self-contained apparatus
5424193, Feb 25 1993 Quidel Corporation Assays employing dyed microorganism labels
5479937, Sep 21 1989 ORASURE TECHNOLOGIES, INC Oral collection device
5494646, Apr 14 1993 Sampling device and sample adequacy system
5504013, Nov 12 1993 Inverness Medical Switzerland GmbH Analytical devices and methods of use thereof
5559041, Dec 18 1989 PBM-SELFCARE, LLC Immunoassay devices and materials
5573009, Sep 21 1989 ORASURE TECHNOLOGIES, INC Oral sample collection method
5573099, Jan 14 1994 J J MACKAY CANADA LIMITED Apparatus and method for identifying metallic tokens and coins
5602040, Apr 27 1987 Inverness Medical Switzerland GmbH Assays
5609160, Mar 30 1995 Ortho Pharmaceutical Corporation In home oral fluid sample collection device and package for mailing of such device
5622871, Apr 27 1987 Inverness Medical Switzerland GmbH Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
5654162, Mar 09 1982 Surmodics, Inc Chemical analysis apparatus and method
5656503, Apr 27 1987 Alere Switzerland GmbH Test device for detecting analytes in biological samples
5679535, Mar 05 1992 University Collge Dublin Apparatus, kit and method for the collection and determination of environmental antigens
5686315, Jun 14 1991 Quidel Corporation Assay device for one step detection of analyte
5712170, Dec 29 1992 Oy Medix Biochemica AB Test strip, its production and use
5714341, Mar 30 1994 ORASURE TECHNOLOGIES, INC Saliva assay method and device
5736322, Jun 07 1995 ORASURE TECHNOLOGIES, INC Synthetic oral fluid standard
5738634, Aug 25 1994 Femtek LLC pH measurement of body fluid
5766961, Jan 11 1991 Quidel Corporation One-step lateral flow nonbibulous assay
5770460, Nov 23 1993 Quidel Corporation One-step lateral flow nonbibulous assay
5786227, Jun 07 1995 Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated Fluid collection kit and method
5786228, Jun 07 1995 Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated Fluid collection kit and method
5786427, Jul 15 1994 IDEMITSU KOSAN CO ,LTD Highly rigid propylenic resin and blow molded article made therefrom
5830154, Jan 11 1996 ORASURE TECHNOLOGIES, INC Device for collecting substances for testing
5830410, Sep 21 1989 ORASURE TECHNOLOGIES, INC Oral collection device and kit
5910122, Jun 04 1996 Americare Health Scan Inc. Saliva collector with an aspirating pipette
5916815, Feb 14 1997 Vintage Capital Group, LLC Assaying system for illicit substances using intentional false positives to initially preserve anonymity
5922283, Jul 07 1997 TECO DIAGNOSTICS, INC ; TECO DIAGNOSTIC, INC Test strips for the determination of the ionic strength or specific gravity of an aqueous sample
5935864, Oct 07 1996 Saliva Diagnostic Systems Inc. Method and kit for collecting samples of liquid specimens for analytical testing
5965453, Jul 12 1995 Charm Sciences, Inc. Test apparatus, system and method for the detection of test samples
5965458, Dec 29 1992 Oy Medix Biochemica A.B. Test strip, its production and use
5968746, Nov 26 1997 Method and apparatus for preserving human saliva for testing
5976895, Mar 11 1996 HEALGEN SCIENTIFIC, LLC Device for the collection, testing and shipment of body fluid samples
5981293, Jun 07 1995 Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated Fluid collection kit and method
5981300, Dec 16 1994 M & M Dental-Medizin GmbH Test kit for analyzing body fluids and analysis method
5986895, Jun 05 1998 Astec International Limited Adaptive pulse width modulated resonant Class-D converter
6022326, Oct 30 1998 Lifepoint, Inc. Device and method for automatic collection of whole saliva
6046058, Nov 20 1998 SUN BIOMEDICAL, LTD Color-coded test strip
6102872, Nov 03 1997 PBI TECHNOLOGY, INC Glucose detector and method
6136610, Nov 23 1998 RELIA BIO-TECH LIMITED Method and apparatus for performing a lateral flow assay
6140136, Sep 18 1998 SYNTRON BIORESEARCH, INC Analytical test device and method of use
6150178, Mar 24 1999 AVITAR, INC Diagnostic testing device
6180395, Jul 12 1995 Charm Sciences, Inc. Reagent chamber for test apparatus and test apparatus
6183972, Jul 27 1998 Siemens Healthcare Diagnostics Inc Method for the determination of analyte concentration in a lateral flow sandwich immunoassay exhibiting high-dose hook effect
6187268, Jul 27 1998 Bayer Corporation Transparent flow through membrane for dry reagent analytical devices
6187269, Mar 17 1995 Inverness Medical Switzerland GmbH Assay devices
6187598, Apr 27 1987 Alere Switzerland GmbH Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
6194221, Nov 19 1996 Wyntek Diagnostics, Inc. Hybrid one-step immunochromatographic device and method of use
6194224, Jul 27 1998 AVITAR, INC Diagnostic membrane containing fatty acid sarcosinate surfactant for testing oral fluid
6221678, Oct 06 1997 ENTERIX INC A DELAWARE CORPORATION ; ENTERIX INC Apparatus and method for analyte detection
6223947, Feb 02 1999 Byron W., Bernard Eye dropper with illuminated tip
6228660, Apr 27 1908 Alere Switzerland GmbH Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
6235241, Nov 12 1993 Alere Switzerland GmbH Reading devices and assay devices for use therewith
6241689, Nov 13 1995 Provalis UK Limited Diagnostic test apparatus
6248598, Sep 17 1998 Immunoassay that provides for both collection of saliva and assay of saliva for one or more analytes with visual readout
6271046, Oct 06 1997 ENTERIX INC Apparatus and method for analyte detection
6277587, Nov 14 1996 The Trustees of Columbia University in the City of New York Method of testing for periodontal disease
6277646, May 05 1997 Siemens Healthcare Diagnostics Inc Fluid specimen collecting and testing apparatus
6291178, Nov 26 1997 Method and apparatus for preserving human saliva for testing
6297020, Mar 01 1999 Siemens Healthcare Diagnostics Inc Device for carrying out lateral-flow assays involving more than one analyte
6303081, Mar 03 1998 ORASURE TECHNOLOGIES, INC Device for collection and assay of oral fluids
6306642, Nov 24 1997 Quidel Corporation Enzyme substrate delivery and product registration in one step enzyme immunoassays
6316205, Jan 28 2000 Genelabs Diagnostics Pte Ltd Assay devices and methods of analyte detection
6338969, Nov 15 1999 Siemens Healthcare Diagnostics Inc Assay test system for regulating temperature
6352862, Feb 17 1989 Inverness Medical Switzerland GmbH Analytical test device for imuno assays and methods of using same
6368873, Apr 09 1998 Inverness Medical Switzerland GmbH Identification of human urine for drug testing
6372513, Apr 19 2000 Agilent Technologies, Inc Device and process for lateral flow saliva testing
6372514, Sep 18 1998 SYNTRON BIORESEARCH, INC Even fluid front for liquid sample on test strip device
6372515, Mar 11 1996 HEALGEN SCIENTIFIC, LLC Device for the testing of fluid samples and process for making the device
6372516, Sep 07 2000 SUN BIOMEDICAL, LTD Lateral flow test device
6375896, Mar 06 1999 Dräger Sicherheitstechnik GmbH Swab analyzer for the immunochemical detection of substances
6375897, Feb 14 2000 Agilent Technologies, Inc Urine collection cup
6379620, Nov 16 1998 ZYON INTL INC Assaying device and method for in field urinalysis
6391652, Aug 07 1997 Nitto Denko Corporation Immunoassay method and immunoassay kit
6403383, Mar 11 1996 HEALGEN SCIENTIFIC, LLC Diagnostic test kit for immunological assays of fluid samples
6418606, Sep 03 1999 Agilent Technologies, Inc Method of manufacturing an assaying device
6423550, Mar 30 1995 Ortho Pharmaceutical Corporation Home oral fluid sample collection device and package for mailing of such device
6429026, Apr 08 1996 Innotrac Diagnostics Oy One-step all-in-one dry reagent immunoassay
6440087, May 25 2001 LABONE, INC Oral fluid collection device and collection method
6443892, Sep 28 2000 UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY, THE Sweat collecting device and methods for use and detection of tampering
6464939, Jul 06 2000 Agilent Technologies, Inc Saliva testing and confirmation device
6468474, Jul 06 2000 Agilent Technologies, Inc Saliva testing and confirmation device
6485982, Jun 27 1988 CHURCH & DWIGHT CO , INC Test device and method for colored particle immunoassay
6489172, Jan 05 2000 Agilent Technologies, Inc Saliva sampling device
6506612, Dec 18 1989 PBM-SELFCARE, LLC Immunoassay devices and materials
6514768, Jan 29 1999 SURMODICS IVD, INC Replicable probe array
6514769, Jul 22 1998 ASSURANCE BIOTECH LLC Multiple analyte assay device with sample integrity monitoring system
6528323, Jun 14 1999 RELIA BIO-TECH LIMITED Bidirectional lateral flow test strip and method
6537823, Apr 24 2000 Sciteck Diagnostics, Inc. Method for detection of bromine in urine using liquid chemistry dry chemistry test pads and lateral flow
6548019, Nov 16 1998 REMBRANDT DIAGNOSTICS, LP Device and methods for single step collection and assaying of biological fluids
6565808, May 18 2001 ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANY Line test device and methods of use
6656744, Aug 09 1995 Quidel Corporation One-step lateral flow assays
6669908, Jul 25 2001 ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANY Urine test device
6673630, Feb 23 2000 Siemens Healthcare Diagnostics Inc Method and apparatus for producing visual results using colorimetric strips
6730268, Nov 16 1998 REMBRANDT DIAGNOSTICS, LP Device and methods for single step collection and assaying of biological fluids
6780160, Jul 25 2002 Akfa Scientific Designs, Inc. Specimen collection and application apparatus
6887681, Mar 31 2000 NEOGEN CORPORATION Apparatus and methods for chemiluminescent assays
6979576, Jul 25 1997 Sekisui Diagnostics, LLC Methods of use of one step immunochromatographic device for Streptococcus A antigen
7048693, Jul 25 2002 ALFA SCIENTIFIC DESIGNS, INC Specimen collection and storage and transport device and method
7114403, May 30 2003 ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANY Fluid collection and application device and methods of use of same
7270959, Jul 25 2001 ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANY Specimen collection container
7300633, Jul 25 2001 ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANY Specimen collection container
7481977, Sep 06 2000 PB DIAGNOSTICS LIMITED Assay device
7517495, Aug 25 2003 ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANY Biological specimen collection and analysis system
20010004532,
20010008614,
20010008774,
20010021536,
20010023076,
20010023324,
20010041368,
20020001845,
20020004019,
20020015663,
20020020713,
20020031840,
20020031845,
20020052050,
20020085953,
20020085958,
20020098512,
20020132267,
20020132370,
20020137231,
20020146346,
20020150884,
20020155028,
20020155029,
20020173047,
20020192839,
20030045003,
20030064526,
20030129088,
20030129673,
20030138971,
20030175992,
20030175993,
20030190259,
20030207466,
20040018636,
20040082878,
20040184954,
20040191760,
20050119589,
20050180882,
20050202568,
20060034728,
20060121548,
20060292035,
20070128070,
20090226883,
20090232702,
CN1084045,
CN1314593,
CN1603823,
CN1614383,
CN1645146,
CN2476023,
EP390984,
EP392096,
EP455916,
EP500172,
EP542107,
EP561322,
EP734684,
EP734685,
EP734686,
EP753148,
EP1216931,
EP1275962,
EP1348960,
GB855916,
JP11304800,
WO15020,
WO20862,
WO25666,
WO64334,
WO108993,
WO149820,
WO181915,
WO2016946,
WO204941,
WO204942,
WO2058600,
WO2059600,
WO207645,
WO2082040,
WO2096480,
WO216946,
WO2005008216,
WO2005050165,
WO2007062575,
WO2008012566,
WO9216842,
WO9311434,
WO9407419,
WO9418892,
WO9502822,
WO9507223,
WO9527205,
WO9720502,
WO9844158,
WO9906827,
WO9922639,
WO9922645,
WO9927139,
WO9950656,
/////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Aug 20 2007Alere Switzerland GmbH(assignment on the face of the patent)
Mar 16 2009Oakville Hong Kong Company LimitedInverness Medical Switzerland GmbHASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0231960142 pdf
Mar 16 2009ACON BIOTECH HANGZHOU CO , LTD Inverness Medical Switzerland GmbHASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0231960142 pdf
Mar 08 2010Inverness Medical Switzerland GmbHAlere Switzerland GmbHCHANGE OF NAME SEE DOCUMENT FOR DETAILS 0248040912 pdf
Oct 29 2020Alere Switzerland GmbHABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANYCONFIRMATORY ASSIGNMENT0542600479 pdf
Date Maintenance Fee Events
Apr 23 2014M1551: Payment of Maintenance Fee, 4th Year, Large Entity.
May 10 2018M1552: Payment of Maintenance Fee, 8th Year, Large Entity.
Apr 12 2022M1553: Payment of Maintenance Fee, 12th Year, Large Entity.


Date Maintenance Schedule
Nov 23 20134 years fee payment window open
May 23 20146 months grace period start (w surcharge)
Nov 23 2014patent expiry (for year 4)
Nov 23 20162 years to revive unintentionally abandoned end. (for year 4)
Nov 23 20178 years fee payment window open
May 23 20186 months grace period start (w surcharge)
Nov 23 2018patent expiry (for year 8)
Nov 23 20202 years to revive unintentionally abandoned end. (for year 8)
Nov 23 202112 years fee payment window open
May 23 20226 months grace period start (w surcharge)
Nov 23 2022patent expiry (for year 12)
Nov 23 20242 years to revive unintentionally abandoned end. (for year 12)